Discovery Communications, Inc. (NASDAQ:DISCA) released Q3 revenues that rose 14.0% year/year to $1.57 bln vs the $1.59 bln consensus, as 32% growth at International Networks was partially offset by a 1% decline at U.S. Networks, primarily due to additional revenues from licensing agreements in the prior year. Discovery Communications, Inc. (NASDAQ:DISCA) stock price closed at $33.31 with the total traded volume of 11.82 Million shares. Its price to sales ratio ended at 2.50. Its market capitalization is 22.851 Billion. The stock owned by the Financial Institutions was 97.10% while by insiders was 0.30%.Zoetis Inc. (NYSE:ZTS) posted its Q3 revenues that rose 9.7% year/year to $1.21 bln vs the $1.15 bln consensus. Co issues in-line guidance for FY14, sees EPS of $1.50-1.54 as compared to $1.52 Capital IQ Consensus Estimate. The firm sees FY14 revs of $4.70B-$4.75B vs. $4.72B Capital IQ Consensus Estimate. Zoetis Inc. (NYSE:ZTS) begun last trade with a price of $38.01 and throughout the trading session climbed at a high of $39.12. The day-trade ended with 3.71% to $39.12. The stock is going forward to its 52 week low with 39.95% and lagging behind from its 52 week high price with 3.22%. ZTS last month stock price volatility remained 2.16%.Covidien plc (NYSE:COV) HawkOne directional atherectomy system receives FDA 510(K) clearance for the treatment of peripheral arterial disease. The latest adding to Covidien's directional atherectomy portfolio, the HawkOne system provides physicians with an enhanced reducing mechanism to more effectively treat the widest variety of plaque in patients with peripheral arterial disease. Covidien plc (NYSE:COV) has the market capitalization of 41.575 Billion. Shares of firm plunged -0.42% to close at $92.03 with the total traded volume of 2.76 Million. The firm has current ratio of 1.80 for the most recent quarter.






